Marsha Novick: Mild nausea, constipation, diarrhea, fatigue, and low appetite are fairly common with GLP-1 medications like semaglutide (Wegovy) and tirzepatide (Zepbound), especially in the first few days after an injection or after a dose increase
These products are not intended to diagnose, treat, cure, or prevent any disease.
However, continuous research and vigilant monitoring are essential to optimize their safe use [55] [56], particularly as these medications are used in broader populations for longer durations
The main goal is to make healthy, sustainable changes that will help maintain weight loss
In de officile productinformatie van Wegovy en Zepbound staat bijvoorbeeld dat deze middelen niet gebruikt mogen worden tijdens zwangerschap en dat semaglutide minstens 2 maanden en tirzepatide minstens 1 maand vr een geplande zwangerschap gestopt moet worden
Ro requires a conversation in real time when required by state law, or when requested by a patient or clinician, said Nicholas Samonas, a spokesperson for the company